{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T21:12:24Z","timestamp":1760303544954,"version":"build-2065373602"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2003,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Human malignant mesotheliomas (HMMs) are aggressive tumors that arise from the mesothelium. They respond poorly to conventional tumor treatment and outcome is often fatal. Inactivating mutations of the neurofibromatosis type 2 (NF2) tumor suppressor gene merlin have been described in nearly 60% of primary malignant mesothelioma and in approximately 20% of the mesothelioma cell lines. Studies regarding human NF2 schwannoma cells revealed a higher proliferation and a larger noninactivating K<jats:sup>+<\/jats:sup> outward current compared with controls. The enhanced proliferation of merlin\u2010deficient NF2 schwannoma cells could be reduced in the presence of quinidine, a K<jats:sup>+<\/jats:sup> channel blocker, whereas the proliferation of normal Schwann cells is not affected. The current study was undertaken to evaluate the effect of quinidine on the proliferation of HMM cell lines in relation to their NF2 status.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Proliferation analyses using bromodeoxyuridine incorporation was performed by immunocytochemical staining and fluorescence assisted cell sorting. The patch\u2010clamp technique was applied for electrophysiologic characterization of the HMM cell lines. The cytochrome P450 2D6 locus, known to be mutated at high frequencies in NF2 patients and to be specifically inhibited by quinidine, was screened for mutations by cycle sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Quinidine selectively reduces the proliferation of merlin\u2010deficient HMM cell lines by causing a G<jats:sub>0<\/jats:sub>\/G<jats:sub>1<\/jats:sub> arrest, whereas the proliferation rates of merlin\u2010expressing HMM cell lines remain unchanged. The effect of quinidine on the proliferation of HMM cell lines appears to be correlated with the NF2 gene status but not with the K<jats:sup>+<\/jats:sup> outward current. No relation to cytochrome P450 2D6 mutations was detected.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Quinidine or quinidine analogs are of potential therapeutic interest for the subset of merlin\u2010deficient mesothelioma tumors. Cancer 2003;97:1955\u201362. \u00a9 2003 American Cancer Society.<\/jats:p><jats:p>DOI 10.1002\/cncr.11275<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.11275","type":"journal-article","created":{"date-parts":[[2003,4,2]],"date-time":"2003-04-02T12:37:22Z","timestamp":1049287042000},"page":"1955-1962","source":"Crossref","is-referenced-by-count":15,"title":["Quinidine impairs proliferation of neurofibromatosis type 2\u2010deficient human malignant mesothelioma cells"],"prefix":"10.1002","volume":"97","author":[{"given":"Tamara","family":"Utermark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexi","family":"Alekov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Abramowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens Oliver","family":"Hanemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(90)90258-C"},{"key":"e_1_2_5_3_2","first-page":"4349","article-title":"Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma","volume":"53","author":"Taguchi T","year":"1993","journal-title":"Cancer Res."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.42"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.24.10854"},{"key":"e_1_2_5_6_2","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido Y","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/363515a0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90406-G"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.2000.0307"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199811)24:3<313::AID-GLIA5>3.0.CO;2-2"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0079-6107(93)90005-5"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1998.093bz.x"},{"key":"e_1_2_5_14_2","first-page":"105","article-title":"A role for K+ channels in cell proliferation","volume":"9","author":"Nilius B","year":"1994","journal-title":"NIPS."},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002329900135"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017564"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1993.sp019872"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017455"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1998.0179"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202141"},{"key":"e_1_2_5_21_2","first-page":"4515","article-title":"Debrisoquine hydroxylase gene polymorphism in neurofibromatosis type 1","volume":"17","author":"Wundrack I","year":"1997","journal-title":"Anticancer Res."},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90192-9"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1136(199806)23:2<89::AID-GLIA1>3.0.CO;2-Z"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002320001052"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.1998.0179"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.004501"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/12.7.1197"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/347709a0"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/347773a0"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91196-F"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199512000-00006"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.4081\/1616"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.11275","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.11275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:29:19Z","timestamp":1760300959000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.11275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,4,15]]}},"alternative-id":["10.1002\/cncr.11275"],"URL":"https:\/\/doi.org\/10.1002\/cncr.11275","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}